ANAlessia Niceforo

Alessia Niceforo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Alessia Niceforo has a total of 15 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Long-term Connectivity between Spinal Cord Tissue Transplants and the Injured Phrenic Motor Network

    by Adam Aaron Hall, Lyandysha Zholudeva, Theresa Connors, Victoria M Spruance, Tara Fortino, Kayla Schardien, Alessia Niceforo, Kimberly J. Dougherty, Liang Qiang, Michael Aron Lane

    Restoring vital motor functions after spinal cord injury (SCI) remains a central challenge in neuroscience and regenerative medicine. Cervical SCI can cause life-threatening respiratory deficits by damaging the phrenic motor network that controls the diaphragm. Cellular transplantation offers a viable means to improve function by providing new neurons that can relay supraspinal drive to denervated spinal phrenic networks, yet the long-term stability of transplants is poorly defined. Here, we examine donor-host neuronal synaptic connectivity in a respiratory model of cervical SCI, 1-year post-transplantation in adult rats. Embryonically-derived spinal cord tissue was transplanted into the lesion cavity one-week post-SCI, and transplant integration and diaphragm function were assessed at 1-month and 1-year post-transplantation. At 1-month, transplant-recipients exhibited significantly greater diaphragm output than injured, vehicle control animals. The extent of recovery at 1-year, however, was significantly less, coinciding with anatomical changes in graft neuronal density and donor-host connectivity, revealed by transneuronal tracing (pseudorabies virus). These results demonstrate that embryonic spinal cord transplants can improve phrenic motor activity after cervical SCI, but that long-term efficacy may be limited by reduced donor-host connectivity.

  • Open Access

    Analysis of astrocyte progenitors derived from human induced pluripotent stem cells in vitro and following transplantation into the intact spinal cord

    by Alessia Niceforo, Ying Jin, Skandha Ramakrishnan, Maurice Lindner-Jackson, Liang O. Qiang, Itzhak Fischer

    Functional improvement following traumatic spinal cord injury (SCI) remains limited, therefore, it is necessary to develop therapeutic interventions such as cell transplantation to replace lost cells and promote connectivity. While transplantation typically focuses on neurons, it is important to include other neural cells, such as immature astrocytes, to provide a permissive environment, promote neuroprotection and regeneration, and ultimately restore connectivity. In this study, we leveraged cellular engineering using human induced pluripotent stem cells (hiPSCs) to generate astrocyte progenitor cells (hAPCs). We tested two hiPSC lines (WTC11 and KOLF2.1J) to characterize the fate of the hAPCs in vitro and following transplantation at the cervical level of the intact spinal cord for up to 3 weeks. Our results demonstrated efficient and consistent differentiation of the hiPSCs into hAPCs, their survival and integration with the adult spinal cord, with no signs of tumors, deleterious outcomes, and unexpected locations. The ability to survive and the absence of adverse effects indicate that hAPC transplantation could be a safe element of therapy in treating spinal cord injuries.

  • Open Access

    Challenges and Efficacy of Astrocyte-to-Neuron Reprogramming in Spinal Cord Injury: In Vitro Insights and In Vivo Outcomes

    by Alessia Niceforo, Lyandysha V. Zholudeva, Silvia Fernandes, Michael A. Lane, Liang Qiang

    Traumatic spinal cord injury (SCI) leads to the disruption of neural pathways, causing loss of neural cells, with subsequent reactive gliosis and tissue scarring that limit endogenous repair. One potential therapeutic strategy to address this is to target reactive scar-forming astrocytes with direct cellular reprogramming to convert them into neurons, by overexpression of neurogenic transcription factors. Here we used lentiviral constructs to overexpress Ascl1 or a combination of microRNAs (miRs) miR124, miR9/9*and NeuroD1 transfected into cultured and in vivo astrocytes. In vitro experiments revealed cortically-derived astrocytes display a higher efficiency (70%) of reprogramming to neurons than spinal cord-derived astrocytes. In a rat cervical SCI model, the same strategy induced only limited reprogramming of astrocytes. Delivery of reprogramming factors did not significantly affect patterns of breathing under baseline and hypoxic conditions, but significant differences in average diaphragm amplitude were seen in the reprogrammed groups during eupneic breathing, hypoxic, and hypercapnic challenges. These results show that while cellular reprogramming can be readily achieved in carefully controlled in vitro conditions, achieving a similar degree of successful reprogramming in vivo is challenging and may require additional steps.